Clinical Trial Update: A Study to Evaluate the Association of Biliary Complications and Treatment Duration in Unresectable BTC Patients

View source ↗

Summary

A completed clinical study from AstraZeneca evaluating the relationship between biliary complications and treatment duration in unresectable biliary tract cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Biliary Tract Cancer | Status: COMPLETED